AI Pioneers Early Detection of Diseases, Surpassing Traditional Methods
McGill University's groundbreaking AI tool offers improved early disease detection by analyzing cellular markers, promising advancements in preventative healthcare.
McGill University's groundbreaking AI tool offers improved early disease detection by analyzing cellular markers, promising advancements in preventative healthcare.
Recent findings from the STEP UP trials indicate that a higher dose of semaglutide could significantly enhance weight loss and improve metabolic health in patients, potentially revolutionizing obesity treatment.
A novel drug showcases promising results in lowering blood pressure and enhancing kidney functions among patients with refractory hypertension and chronic kidney disease.
Researchers at MIT's CSAIL and McMaster University have leveraged generative AI to expedite the mapping of a new antibiotic's impact on gut bacteria, significantly accelerating a process that traditionally would take years.
A landmark Scandinavian study demonstrates that low-dose aspirin can significantly reduce the recurrence of colon and rectal cancer in patients with certain genetic mutations, positioning it as a promising precision medicine option.
Stunning imagery reveals the effects of polymyxins, essential antibiotics, on bacterial defenses. This insight into how antibiotics function could transform treatment strategies for recurring infections, addressing a critical challenge in modern healthcare.
A comprehensive study sponsored by the NIH uncovers that the loss of smell due to COVID-19 is more widespread and persistent than previously thought. This condition affects even those without obvious symptoms, emphasizing the need for standardized scent testing and further exploration of treatment options.
New research reveals an alarming second phase in black mamba venom effects on human victims, challenging the current understanding of treatment efficacy. Scientists have discovered how the venom can trigger debilitating muscle spasms even after antivenom administration.
Scientists at Ohio State have uncovered why cancer immunotherapy often fails, tracing it to the malfunction of T cells burdened by misfolded proteins. Addressing this malfunction could enhance the effectiveness of immunotherapy treatments.
Praxipal, a Berlin-based technology company, has raised .7 million in seed funding. The startup aims to transform how healthcare receptions operate by integrating AI-powered solutions, enhancing efficiency and patient service.
Stay informed with curated insights delivered weekly to your inbox.